Your browser doesn't support javascript.
loading
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study.
Rise, Henning H; Brune, Synne; Chien, Claudia; Berge, Tone; Bos, Steffan D; Andorrà, Magí; Valdeolivas, Irene Pulido; Beyer, Mona K; Sowa, Piotr; Scheel, Michael; Brandt, Alexander U; Asseyer, Susanna; Blennow, Kaj; Pedersen, Mads L; Zetterberg, Henrik; de Schotten, Michel Thiebaut; Cellerino, Maria; Uccelli, Antonio; Paul, Friedemann; Villoslada, Pablo; Harbo, Hanne F; Westlye, Lars T; Høgestøl, Einar A.
Affiliation
  • Rise HH; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Department of Psychology, University of Oslo, Oslo, Norway.
  • Brune S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Chien C; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin & Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Experimental and Clinical Research Center, Germany; Charité -Universitätsmedizin Berlin, Corporate Membe
  • Berge T; Department of Mechanical, Electronics and Chemical Engineering, Oslo Metropolitan University, Oslo, Norway; Department of Research, Innovation and Education, Oslo University Hospital, Oslo, Norway.
  • Bos SD; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Andorrà M; Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain.
  • Valdeolivas IP; Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain.
  • Beyer MK; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Sowa P; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Scheel M; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, NeuroCure Clinical Research Center, Germany; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Neurorad
  • Brandt AU; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin & Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Experimental and Clinical Research Center, Germany; Charité -Universitätsmedizin Berlin, Corporate Membe
  • Asseyer S; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin & Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Experimental and Clinical Research Center, Germany.
  • Blennow K; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Pedersen ML; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Department of Psychology, University of Oslo, Oslo, Norway.
  • Zetterberg H; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdo
  • de Schotten MT; Brain Connectivity and Behaviour Laboratory, Sorbonne Universities, Paris, France; Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives- UMR 5293, CNRS, CEA University of Bordeaux, Bordeaux, France.
  • Cellerino M; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
  • Uccelli A; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Paul F; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin & Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Experimental and Clinical Research Center, Germany; Charité -Universitätsmedizin Berlin, Corporate Membe
  • Villoslada P; Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain.
  • Harbo HF; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Westlye LT; NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Department of Psychology, University of Oslo, Oslo, Norway; KG Jebsen, Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.
  • Høgestøl EA; Department of Psychology, University of Oslo, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Neurology, Oslo University Hospital, Oslo, Norway. Electronic address: einar.august@gmail.com.
Neuroimage Clin ; 35: 103099, 2022.
Article de En | MEDLINE | ID: mdl-35772194

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Substance blanche / Sclérose en plaques Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male Langue: En Journal: Neuroimage Clin Année: 2022 Type de document: Article Pays d'affiliation: Norvège

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Substance blanche / Sclérose en plaques Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male Langue: En Journal: Neuroimage Clin Année: 2022 Type de document: Article Pays d'affiliation: Norvège